Results 71 to 80 of about 4,918 (159)

A comparative study on vildagliptin brand and its generic equivalents using dissolution test as quality control measure tool

Scientific Reports
Market drugs including brand or generic with poor quality, don’t meet the acceptable standard guidelines. Vildagliptin is an important antidiabetic drugs used in monotherapy or in combinations protocols for treatment of diabetes mellites.
Ghadah H. Altoum, Fouza K. AL-Enazi, Mubarl M. Abudahash, Reem A. AL-Fadhli, Naif Alenzi   +4 more
doaj   +1 more source

Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderly

Drug Design, Development and Therapy, 2014
Antoni Sicras-Mainar,1 Ruth Navarro-Artieda2 1Dirección de Planificación, Badalona Serveis Assistencials SA, 2Documentación Médica, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain Background: The aim of this study ...
Sicras-Mainar A, Navarro-Artieda R
doaj  

Phosphatidylinositol-3-kinase/Protein Kinase B (PI3K/AKT) and Nucleotide-Binding Oligomerization Domain-like Receptor Family Pyrin Domain Containing 3 (NLRP3) Inflammasome Modulation Underlies the Neuroprotective Effects of Vildagliptin in a Rotenone-Induced Mouse Model of Parkinson's Disease. [PDF]

ACS Pharmacol Transl Sci
Patel D, Soni R, Bhogal I, Roy S, Shah J.   +4 more
europepmc   +1 more source

Safety and Tolerability of Vildagliptin 100 mg Sustained-Release Formulation in Type 2 Diabetes Mellitus: Results From a Prospective, Multicenter, Single-Arm, Post-marketing Surveillance Study. [PDF]

Cureus
Soni P, Sonawane A, Gaidhani S, Baxi N, Malhotra D, Acharya S.   +5 more
europepmc   +1 more source

Docosahexaenoic acid is comparable to vildagliptin in improving hyperglycemia and pancreatic insulin signaling of diabetic rats via SIRT1/Akt/PI3K pathway. [PDF]

Sci Rep
Abo-Saif MA, Werida RH, Mohamed SA, Khedr NF.   +3 more
europepmc   +1 more source

Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Acute Kidney Injury in Patients With Diabetes Mellitus: A Disproportionality Analysis Based on the FAERS. [PDF]

In Vivo
Ohyama K, Takahashi T, Akiyama S, Hori Y.   +3 more
europepmc   +1 more source

Ameliorative effects of Wiryeongtang (herbal medicine) on cardiorenal complications via modulation of inflammatory and fibrotic responses in diabetic mice. [PDF]

Integr Med Res
Yoon JJ, Kim HY, Tai AL, Yang YJ, Park SJ, Lee HS.   +5 more
europepmc   +1 more source

Bioequivalence assessment between two formulations of a film-coated fixed-dose combination of metformin and vildagliptin (850/50mg) in healthy Tunisian subjects under fed conditions. [PDF]

Sci Rep
Ferchichi K, Gaies E, Ben Hammamia S, El Jebari H, Daldoul M, Ghorbel S, Srairi S, Guermazi S, Gorgi Y, Boutiba I, Bouzid K, Abbessi A, Daghfous R, Ben Sassi M, Trabelsi S.   +14 more
europepmc   +1 more source

Evaluation of the therapeutic effect of new hypoglycemic drugs on patients with heart failure with reduced ejection fraction and type 2 diabetes: a systematic review and network meta-analysis. [PDF]

Front Cardiovasc Med
Chen XR, Mao XP, Luo D, Yu CQ, Bai JN.
europepmc   +1 more source

Vildagliptin and Omarigliptin Differentially Bind to DPP-4 Homodimers and Modulate Osteoclast-Mediated Bone Resorption. [PDF]

Compr Physiol
Aeimlapa R, Panmanee J, Teerapornpuntakit J, Wongdee K, Thongbunchoo J, Panupinthu N, Svasti S, Apaijai N, Sa-Nguanmoo P, Chattipakorn S, Chattipakorn N, Charoenphandhu N.   +11 more
europepmc   +1 more source